Medical Device News Magazine

Coretrust Capital Partners Advises: It’s Safe To Return To The Office. Company Deploys First AI COVID-19 Disinfecting Robots At Properties Plus Other Anti-COVID Tech

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Coretrust Capital Partners has unveiled ADIBOT UV-C Disinfecting Robots that disinfect air and surfaces against COVID-19 and other harmful airborne pathogens as the centerpiece of multiple anti-COVID technologies at its office properties, FourFortyFour, in downtown Los Angeles at 444 South Flower St., 2 Liberty Place in downtown Philadelphia and PASARROYO in Pasadena, CA.

As mask mandates are lifted and people return to the office after a year of isolation, the company has taken building technology to a new level to create safe, healthy and stress-free office environments.

The ADIBOT UV-C Disinfection system is created and manufactured by UBTECH Robotics, a global leader in intelligent humanoid robotics and AI technologies.  The robots use UV-C technology that disinfects air and targeted surfaces to deactivate the DNA and RNA of harmful pathogens.  By using UV-C, ADIBOT also reduces interaction with harmful chemicals, one-time use plastics and chemical disposal into the environment.  The system effectively disinfects 99.9 percent of targeted areas with minimal downtime.

“UBTECH located its North American R&D headquarters at our Pasadena property and, as soon as we became aware of the UV-C robots, we recognized they would be incredible additions to our health and wellness technology,” said Thomas S. Ricci, Managing Principal and a founder of Coretrust. “As our tenant customers return to the workplace, many starting this month, health and wellness issues are paramount to staff confidence.  The robots are visible symbols of the anti-COVID technology that stands behind the environmental health of our buildings.

“We know of no other office owner that has the combination of environmental technology and health and safety operational protocols to combat COVID-19 and other viruses,” Ricci added.

“The ADIBOT UV-C system offers a long-term strategic solution to help protect people from COVID-19 pathogens or other viruses,” said John Rhee, Senior Vice President – General Manager, North America, UBTECH.  “We spend much of our daily lives at our offices so it is a smart strategy for landlords to use intelligent robots as an added cleaning layer to create safer and healthier workplaces.

“Our robots are just one of the technologies that Coretrust properties deploy to protect tenants,” Rhee said. “We are proud to partner with Coretrust because UBTECH chose to locate its North American R&D headquarters at the PASARROYO campus.  Like every employer, we wanted to make sure our office held high standards of cleaning and disinfection to provide a safe environment for our staff and Coretrust’s operations and technology allow us to accomplish these shared goals,” he concluded.

A major element in achieving virtually hospital grade indoor air quality at all Coretrust properties is the patented Biowall MAX, an Ultraviolet Germicidal Irradiation Air Disinfection system that sterilizes 99.9 percent of airborne bio-contaminants. Sanuvox Technologies Inc., a global leader in ultraviolet air purification, installed the most advanced and effective in-duct UVC air sterilization systems for Coretrust.  The Biowall MAX virtually eliminates the HVAC (Heating Ventilation Air Conditioning) system as a mode of virus transmission.

Along with the Biowall MAX system, Coretrust further enhanced indoor air quality by installing the highest effective MERV air filters, making frequent fresh air purges and allowing maximum fresh air ventilation throughout the day.  In addition, Ricci points out that Coretrust is one of the first landlords to provide continuous elevator air purification through bi-polar ionization units atop each cab.

A major Coretrust innovation was hacking the curtain wall of the FourFortyFour tower to create a 1,000-square-foot loggia terrace that brings fresh air and sunlight into the 22,500-square-foot Workplace Innovation Lab on the sixth floor.  Similar indoor terraces can be created for occupants at all our properties as desired, said Ricci.

Coretrust also added touchless destination dispatch systems to completely modernized elevators at its buildings that allow tenants to use personalized access cards to call cars without touching buttons. Coretrust has further minimized touch points by adding automatic doors, touchless parking garage entry, touchless security access for visitors, touchless restroom fixtures and NanoSeptic film on common door handles for continuous disinfecting.

By virtue of its comprehensive programs, Coretrust earned the first three global UL Verified Healthy Buildings Marks for Indoor Air and Water Quality for FourFortyFour, 2 Liberty Place and PASARROYO.  The UL certification verifies the effectiveness of Coretrust’s technological and operational improvements at its properties, setting the bar for landlords across the U.S.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”